Beam Therapeutics Inc. (BEAM): Price and Financial Metrics

Beam Therapeutics Inc. (BEAM): $28.81

0.11 (+0.38%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

C

Add BEAM to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#214 of 336

in industry

BEAM Price/Volume Stats

Current price $28.81 52-week high $49.50
Prev. close $28.70 52-week low $20.84
Day low $28.00 Volume 263,496
Day high $29.12 Avg. volume 1,227,685
50-day MA $25.81 Dividend yield N/A
200-day MA $25.89 Market Cap 2.39B

BEAM Stock Price Chart Interactive Chart >


Beam Therapeutics Inc. (BEAM) Company Bio


Beam Therapeutics Inc., a biotechnology company, engages in developing precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing therapies for the development of sickle cell disease and beta-thalassemia; CAR-T cell therapies for pediatric T-cell acute lymphoblastic leukemia and pediatric acute myeloid leukemia; therapies for alpha-1 antitrypsin deficiency and glycogen storage disorder 1A; and therapies for ocular and central nervous system disorders. It has a research and clinical collaboration agreement with Magenta Therapeutics, Inc. Beam Therapeutics Inc. was founded in 2017 and is based in Cambridge, Massachusetts.


BEAM Latest News Stream


Event/Time News Detail
Loading, please wait...

BEAM Latest Social Stream


Loading social stream, please wait...

View Full BEAM Social Stream

BEAM Price Returns

1-mo 15.01%
3-mo 17.59%
6-mo 20.14%
1-year N/A
3-year N/A
5-year N/A
YTD 5.84%
2023 -30.40%
2022 -50.92%
2021 -2.39%
2020 N/A
2019 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!